Study Evaluating The Potential Effect Of Rifampin On The Pharmacokinetics Of Neratinib

Clinical trial NCT00864487 · COMPLETED

Trial details

NCT number: NCT00864487
Sponsor: Puma Biotechnology, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2009-04-01
Primary completion: 2009-05-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.